Reduction in IL-33 plasma levels might be involved in T cell dysregulation in chronic lymphocytic leukemia.

about

Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33.Possible Role of Interleukin-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity.The Role of IL-33/ST2 Pathway in Tumorigenesis

P2860

Q37251140-28349213-9F49-4F1D-BC25-4E84894FC1BC Q41519292-29A53D2E-0164-45AD-9868-63E02E9B6F7E Q58756972-BA7BB2F6-B63E-4FBA-B412-AD2CA7C8F5E4

P2860

Reduction in IL-33 plasma levels might be involved in T cell dysregulation in chronic lymphocytic leukemia.

Item

http://www.wikidata.org/entity/Q44628423

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Reduction in IL-33 plasma leve ...... chronic lymphocytic leukemia.

@en

Reduction in IL-33 plasma leve ...... chronic lymphocytic leukemia.

@nl

type

Item

label

Reduction in IL-33 plasma leve ...... chronic lymphocytic leukemia.

@en

Reduction in IL-33 plasma leve ...... chronic lymphocytic leukemia.

@nl

prefLabel

Reduction in IL-33 plasma leve ...... chronic lymphocytic leukemia.

@en

Reduction in IL-33 plasma leve ...... chronic lymphocytic leukemia.

@nl

P1476

Reduction in IL-33 plasma leve ...... chronic lymphocytic leukemia.

@en

P2093

Andrea Alonci

http://www.w3.org/2001/XMLSchema#string

Caterina Musolino

http://www.w3.org/2001/XMLSchema#string

Demetrio Gerace

http://www.w3.org/2001/XMLSchema#string

Laura Calabrò

http://www.w3.org/2001/XMLSchema#string

Salvatore Saitta

http://www.w3.org/2001/XMLSchema#string

P2860

IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells

Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells.

Signaling by IL-31 and functional consequences.

Expression feature of CD3, FcεRIγ, and Zap-70 in patients with chronic lymphocytic leukemia.

The enigmatic processing and secretion of interleukin-33.

Nurture versus nature: the microenvironment in chronic lymphocytic leukemia.

Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease.

Decreased plasma levels of IL-33 could contribute to the altered function of Th2 lymphocytes in patients with polycythemia vera and essential thrombocythemia.

P304

165-166

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000353476

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24217710

http://www.w3.org/2001/XMLSchema#string

P921

lymphocyte

Reduction in IL-33 plasma levels might be involved in T cell dysregulation in chronic lymphocytic leukemia.

about

P2860

P2860

Reduction in IL-33 plasma levels might be involved in T cell dysregulation in chronic lymphocytic leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921